title: Gatifloxacin 0.3% Versus Fortified Tobramycin-Cefazolin in Treating Nonperforated Bacterial Corneal Ulcers: Randomized, Controlled Trial.
authors.affiliation: Cornea and Refractive Surgery Services, Dr. Shroff's Charity Eye Hospital, New Delhi, India.
authors.forename: Hafsa
authors.initials: H
authors.lastname: Bashir
authors.forename: Abhishek
authors.initials: A
authors.lastname: Dave
authors.forename: Umang
authors.initials: U
authors.lastname: Mathur
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002437:Cefazolin / Q000627:therapeutic use*; D003320:Corneal Ulcer / Q000188:drug therapy; D004359:Drug Therapy, Combination; D015818:Eye Infections, Bacterial / Q000188:drug therapy; D024841:Fluoroquinolones / Q000627:therapeutic use; D006801:Humans; D014031:Tobramycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D024841:Fluoroquinolones; D002437:Cefazolin; D014031:Tobramycin